Trends in Prostate Cancer Incidence and Mortality Rates
In this cohort study among California residents, the incidence of distant stage prostate cancer increased throughout the state between 2011 and 2021. Mortality rates plateaued between 2012 and 2021, ending previous decades of decline. Implementation of more effective prostate cancer screening strategies are critically needed.
Authors
- Erin L. Van Blarigan (ORCID: https://orcid.org/0000-0001-5079-3385)
- Samuel L. Washington (ORCID: https://orcid.org/0000-0002-2467-6115)
- Iona C. Cheng (ORCID: https://orcid.org/0000-0003-4132-2893)
- Stacey A. Kenfield (ORCID: https://orcid.org/0000-0002-1585-7352)
- Scarlett Lin Gomez (ORCID: https://orcid.org/0000-0002-5143-4867)
- Matthew R. Cooperberg (ORCID: https://orcid.org/0000-0003-4339-6685)
- Meg McKinley (ORCID: https://orcid.org/0000-0003-1260-9764)
Institutions
- University of California, San Francisco (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.56825
- Citations
- 30
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 31.36
Funders
- Pfizer
- California Department of Public Health
- University of Southern California
- Cancer Registry of Greater California
- Veracyte
- Astellas Pharma
- Centers for Disease Control and Prevention
- University of California, San Francisco
- National Cancer Institute